These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26082667)
1. Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population. Lange J; Richard P; Bradley N Med Devices (Auckl); 2015; 8():255-64. PubMed ID: 26082667 [TBL] [Abstract][Full Text] [Related]
2. Formative usability evaluation of a fixed-dose pen-injector platform device. Lange J; Nemeth T Med Devices (Auckl); 2018; 11():105-112. PubMed ID: 29670411 [TBL] [Abstract][Full Text] [Related]
3. Usability of devices for self-injection: results of a formative study on a new disposable pen injector. Lange J; Richard P; Bradley N Med Devices (Auckl); 2014; 7():195-203. PubMed ID: 24966698 [TBL] [Abstract][Full Text] [Related]
4. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration. Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104 [TBL] [Abstract][Full Text] [Related]
5. Formative and Validation Human Factors studies of a new disposable autoinjector for subcutaneous delivery of chronic disease therapies. Lageat C; Combedazou A; Ramus C; Guerrero K; Frolet C; Glezer S Expert Opin Drug Deliv; 2021 Nov; 18(11):1761-1775. PubMed ID: 34448423 [TBL] [Abstract][Full Text] [Related]
6. Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis. Schiff M; Koo J; Jin E; Schiller E; Day A; Stevens R; Laskar C Adv Ther; 2016 Feb; 33(2):199-213. PubMed ID: 26833303 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis. Hudry C; Lebrun A; Moura B; Zinovieva E; Backers O; Herman-Demars H Rheumatol Ther; 2017 Jun; 4(1):183-194. PubMed ID: 28243967 [TBL] [Abstract][Full Text] [Related]
8. Design Development of the SMARTCLIC Berman K; Moss S; Holden-Theunissen B; Satou N; Okada K; Latymer M; Antalfy A Adv Ther; 2023 Jul; 40(7):3070-3086. PubMed ID: 37199860 [TBL] [Abstract][Full Text] [Related]
9. Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis. Schwarzenbach F; Dao Trong M; Grange L; Laurent PE; Abry H; Cotten J; Granger C Patient Prefer Adherence; 2014; 8():199-209. PubMed ID: 24627625 [TBL] [Abstract][Full Text] [Related]
10. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment. Jeannerot F; Stüdeli T; Gunther-LaVergne L; Hirning D; Schertz J Expert Opin Drug Deliv; 2016 Sep; 13(9):1221-9. PubMed ID: 27329677 [TBL] [Abstract][Full Text] [Related]
11. Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience. Callis Duffin K; Bukhalo M; Bobonich MA; Shrom D; Zhao F; Kershner JR; Gill A; Pangallo B; Shuler CL; Bagel J Med Devices (Auckl); 2016; 9():361-369. PubMed ID: 27785115 [TBL] [Abstract][Full Text] [Related]
12. Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth. Travanty MN; Calawa B; Shalaby WS; Jozwiakowski MJ; Haraldsen KB Med Devices (Auckl); 2018; 11():241-252. PubMed ID: 30100767 [TBL] [Abstract][Full Text] [Related]
13. Quantifying Patient Capabilities and Setting the Stage for Future Development: Insights from a Sensor-Augmented Simulated Use Study with Pen Injectors. Lange J; Schneider AE; Jordi C Med Devices (Auckl); 2024; 17():271-283. PubMed ID: 39099757 [TBL] [Abstract][Full Text] [Related]
14. A pen device for injection of recombinant human growth hormone: a European usability engineering study. Cachemaille A; Warren SE; Moss S Expert Opin Drug Deliv; 2020 Jul; 17(7):1041-1048. PubMed ID: 32543910 [TBL] [Abstract][Full Text] [Related]
15. Evolution of the RebiSmart Lin YT; Will T; Wickham C; Boeree P; Jack D; Keiser M Patient Prefer Adherence; 2023; 17():1923-1933. PubMed ID: 37581193 [TBL] [Abstract][Full Text] [Related]
16. US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use. Mahony M; Dwyer A; Barkume R; Strochlic A; Jeannerot F; Stüdeli T Expert Opin Drug Deliv; 2018 Jan; 15(1):5-15. PubMed ID: 29198148 [TBL] [Abstract][Full Text] [Related]
17. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Guerlain S; Hugine A; Wang L Ann Allergy Asthma Immunol; 2010 Feb; 104(2):172-7. PubMed ID: 20306821 [TBL] [Abstract][Full Text] [Related]
18. Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients. Brand-Schieber E; Munjal S; Kumar R; Andre AD; Valladao W; Ramirez M Med Devices (Auckl); 2016; 9():131-7. PubMed ID: 27313479 [TBL] [Abstract][Full Text] [Related]
19. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study. Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898 [TBL] [Abstract][Full Text] [Related]
20. Formative Study on the Wearability and Usability of a Large-Volume Patch Injector. Lange J; Schneider A; Jordi C; Lau M; Disher T Med Devices (Auckl); 2021; 14():363-377. PubMed ID: 34815721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]